DK665187A - Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf - Google Patents

Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf

Info

Publication number
DK665187A
DK665187A DK665187A DK665187A DK665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A DK 665187 A DK665187 A DK 665187A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
immunoglobulin conjugates
conjugates
immunoglobulin
Prior art date
Application number
DK665187A
Other languages
English (en)
Other versions
DK665187D0 (da
Inventor
Gary Allen Koppel
George Davon Kennedy
Henry Kenneth Armour
William Leonard Scott
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK665187D0 publication Critical patent/DK665187D0/da
Publication of DK665187A publication Critical patent/DK665187A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK665187A 1986-12-24 1987-12-17 Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf DK665187A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94635186A 1986-12-24 1986-12-24

Publications (2)

Publication Number Publication Date
DK665187D0 DK665187D0 (da) 1987-12-17
DK665187A true DK665187A (da) 1988-06-25

Family

ID=25484355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK665187A DK665187A (da) 1986-12-24 1987-12-17 Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf

Country Status (14)

Country Link
EP (1) EP0272891A3 (da)
JP (1) JPS63166897A (da)
KR (1) KR880007531A (da)
CN (1) CN1018649B (da)
AU (1) AU590462B2 (da)
DK (1) DK665187A (da)
HU (1) HU205135B (da)
IE (1) IE873450L (da)
IL (1) IL84842A0 (da)
MX (1) MX9847A (da)
NZ (1) NZ222981A (da)
PT (1) PT86377B (da)
RU (1) RU1787160C (da)
ZA (1) ZA879473B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2075040T3 (es) * 1988-02-16 1995-10-01 Lilly Co Eli 2',3'-dideoxi-2',2'-difluoronucleosidos.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5273743A (en) * 1990-03-09 1993-12-28 Hybritech Incorporated Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
IL97459A0 (en) * 1990-03-09 1992-06-21 Hybritech Inc Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
WO1992014758A1 (en) * 1991-02-13 1992-09-03 The Austin Research Institute Conjugate molecules
CN1076197C (zh) * 1997-08-20 2001-12-19 许跃远 一种治疗乳腺疾病的药
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
EP1465615B1 (en) 2002-01-15 2012-08-01 Trustees of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
EP1567169A4 (en) 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
CA2670099A1 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
EA022166B1 (ru) 2008-01-11 2015-11-30 Ритэ Фамэсутиклс, Инк. Синтетические тритерпеноиды и их применение в лечении заболеваний
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
US7943778B2 (en) 2008-04-18 2011-05-17 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
CN102083442B (zh) 2008-04-18 2014-08-13 里亚塔医药公司 抗氧化剂炎症调节剂:在c-17具有氨基和其它修饰的齐墩果酸衍生物
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721665C (en) 2008-04-18 2017-01-24 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
US8752322B2 (en) 2012-01-13 2014-06-17 Taurus International Manufacturing, Inc. Body contoured handgun
RS57449B1 (sr) 2012-04-04 2018-09-28 Halozyme Inc Kombinovana terapija sa hijaluronidazom i taksanom koji ciljno deluje na tumor
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
EP0123441B1 (en) * 1983-03-30 1990-10-03 Lilly Industries Limited Vincaleukoblastine derivatives
GB2137210B (en) * 1983-03-30 1986-11-19 Lilly Industries Ltd Immunoglobulin conjugates
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
IL77133A (en) * 1984-12-04 1991-01-31 Lilly Co Eli Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4762823A (en) * 1985-10-16 1988-08-09 Sloan-Kettering Institute For Cancer Research Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides

Also Published As

Publication number Publication date
IE873450L (en) 1988-06-24
NZ222981A (en) 1989-08-29
PT86377B (pt) 1990-11-20
DK665187D0 (da) 1987-12-17
CN87108348A (zh) 1988-07-13
RU1787160C (ru) 1993-01-07
PT86377A (en) 1988-01-01
KR880007531A (ko) 1988-08-27
MX9847A (es) 1993-11-01
AU8265987A (en) 1988-06-30
CN1018649B (zh) 1992-10-14
HUT45547A (en) 1988-07-28
EP0272891A2 (en) 1988-06-29
JPS63166897A (ja) 1988-07-11
HU205135B (en) 1992-03-30
EP0272891A3 (en) 1989-11-08
AU590462B2 (en) 1989-11-02
ZA879473B (en) 1989-08-30
IL84842A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DK665187A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
DK260687A (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK484587D0 (da) Antioxidant og fremgangsmaade til fremstilling heraf
DK522487A (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK301886D0 (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK130182A (da) Antagonister for argininvasopressin og fremgangsmaade til fremstilling heraf
DK134288D0 (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK564889D0 (da) Fastgoerelseselement og fremgangsmaade til fremstilling heraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK487688A (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK454784A (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK25388A (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK160087D0 (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment